HBV Seq2 aa:28-39
HBV Seq2 aa:28-39 is a HBsAg peptide, which binds to major histocompatibility complex (MHC) class I molecules[1][2].
Product Specifications
CAS Number
168417-72-9
UNSPSC
12352209
Target
HBV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-seq2-aa-28-39.html
Solubility
H2O
Smiles
O=C([C@H]1N(CCC1)C([C@@H](N)[C@@H](C)CC)=O)N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CC2=CNC3=CC=CC=C23)C(N[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)CC4=CNC5=CC=CC=C45)=O)=O)=O)=O)=O)=O
Molecular Formula
C67H97N15O20
Molecular Weight
1432.58
References & Citations
[1]Ito H, et al. Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand. Virology. 2019 May;531:233-239. |[2]Ito H, et al. Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand. J Viral Hepat. 2017 Feb;24 (2) :155-162.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-D211100-2.5G 2.5 g
(3S,4aS,8aS)-Decahydro-N-t-butyl-3-isoquinolinecarboxamide
Sign In for Pricing
View Details